-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Sanara MedTech, Raises Price Target to $51

Benzinga·03/26/2025 10:47:52
Listen to the news
HC Wainwright & Co. analyst Yi Chen maintains Sanara MedTech (NASDAQ:SMTI) with a Buy and raises the price target from $50 to $51.